<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The extent and clinical manifestations of <z:hpo ids='HP_0011009'>acute</z:hpo> human parvovirus B19 (B19) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> were assessed in previously healthy hospitalized children admitted with clinical syndromes potentially associated the virus </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: The study was prospective and was conducted between October 2002 and August 2004 in the pediatric departments of 3 hospitals in Israel </plain></SENT>
<SENT sid="2" pm="."><plain>The survey included previously healthy children who were hospitalized with 1 or more of the following <z:hpo ids='HP_0011009'>acute</z:hpo> diseases: <z:hpo ids='HP_0011009'>acute</z:hpo> nonallergic <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">exanthema</z:e>, <z:hpo ids='HP_0001945'>fever</z:hpo> for &gt;1 week, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> or <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> nonbacterial <z:hpo ids='HP_0003040'>arthropathy</z:hpo>, immune thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="0" ids="16039">ITP</z:chebi>), Henoch-Sch√∂nlein <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="24" ids="50430">HSP</z:chebi>) and aseptic <z:hpo ids='HP_0001287'>meningitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A control group of children with a proven, non-B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was also studied </plain></SENT>
<SENT sid="4" pm="."><plain>Serum samples obtained from each child on admission were tested for B19 DNA by real-time PCR and B19 IgM by ELISA </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was defined by the following criteria: positive serum B19-DNA and/or B19 IgM, negative serum B19 IgG, and no other proven <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Overall, 167 children were included in the study </plain></SENT>
<SENT sid="7" pm="."><plain>The mean age was 5.5 +/- 4.6 years (range, 0.5-17), males and females equally divided </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was demonstrated in 12.6% (n = 21) of the children </plain></SENT>
<SENT sid="9" pm="."><plain>Both tests were performed in 19 children and were positive in 10 (53%) </plain></SENT>
<SENT sid="10" pm="."><plain>In 7 and 2 children, only B19-DNA or B19 IgM, respectively, was positive </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was documented in 27% (10/39) of children who presented with a variety of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">exanthema</z:e> diseases; 9% (5/57) of children with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003040'>arthropathy</z:hpo> (<z:hpo ids='HP_0000001'>all</z:hpo> 5 had transient <z:hpo ids='HP_0100769'>synovitis</z:hpo>); 10% (2/21) of children with <z:hpo ids='HP_0001945'>fever</z:hpo> &gt;1 week, both presented as <z:e sem="disease" ids="C0272210" disease_type="Disease or Syndrome" abbrv="">mononucleosis syndrome</z:e>; and in 44% (4/9) of children with transient <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>No <z:hpo ids='HP_0011009'>acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was demonstrated in 15 children with <z:chebi fb="0" ids="16039">ITP</z:chebi>, 9 with <z:chebi fb="24" ids="50430">HSP</z:chebi>, and 6 with aseptic <z:hpo ids='HP_0001287'>meningitis</z:hpo> and among 70 children in the control group </plain></SENT>
<SENT sid="13" pm="."><plain>By logistic regression analysis, manifestations significantly associated with <z:hpo ids='HP_0011009'>acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> were <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">exanthema</z:e> (OR 2.9; 95% CI = 1.1-7.5), <z:hpo ids='HP_0001903'>anemia</z:hpo> (OR 6.35; 95% CI = 2.2-18.2) and <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> (OR 4.14; 95% CI =1.2-14.2) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011009'>Acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was documented among 12.6% of children hospitalized with clinical syndrome potentially associated with the virus </plain></SENT>
<SENT sid="15" pm="."><plain>Clinical and laboratory features associated with <z:hpo ids='HP_0011009'>acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> were <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">exanthema</z:e>, <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>Determination of both serum B19-DNA and serum B19 IgM should be performed for the accurate diagnosis of <z:hpo ids='HP_0011009'>acute</z:hpo> B19 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>